Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
119 participants
INTERVENTIONAL
2008-02-29
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
homeopathic ear drops in addition to standard care for otitis media
Hyland's earache drops
3-4 drops in affected ear 3 times a day as needed for up to 5 days
2
No ear drops, standard care for otitis
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyland's earache drops
3-4 drops in affected ear 3 times a day as needed for up to 5 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with acute otitis media
* Parents rate symptoms as a "moderate problem" or more
Exclusion Criteria
* Receipt of antibiotics within 2 days
* Perforated ear drum or bullous lesion
* Receipt of homeopathic treatment within 30 days
6 Months
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Standard Homeopathic Company
INDUSTRY
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Washington
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A Taylor
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Washington Medical Center-Roosevelt Pediatric Care Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-9092-B 01
Identifier Type: -
Identifier Source: secondary_id
33097-B
Identifier Type: -
Identifier Source: org_study_id